Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Alemtuzumab in multiple sclerosis: latest evidence and clinical prospects.
Targeting Dynamic Balance in Falls-Prevention Interventions in Multiple Sclerosis: Recommendations from the International MS Falls Prevention Research Network.
Intrinsic Functional Plasticity of the Sensorimotor Network in Relapsing-Remitting Multiple Sclerosis: Evidence from a Centrality Analysis.
Simultaneous Development of Acute Disseminated Encephalomyelitis and Guillain-Barré Syndrome Associated with H1N1 09 Influenza Vaccination.
The TASK1 channel inhibitor A293 shows efficacy in a mouse model of multiple sclerosis.
Fumaric acid esters in psoriasis and multiple sclerosis.
Vitamin D in inflammatory diseases.
Glatiramer acetate to treat multiple sclerosis during pregnancy and lactation: a safety evaluation.
The fatigue-motor performance paradox in multiple sclerosis.
Use of a Standardized MxA Protein Measurement-Based Assay for Validation of Assays for the Assessment of Neutralizing Antibodies Against Interferon-β
Homing frequency of human T cells inferred from peripheral blood depletion kinetics after sphingosine-1-phosphate receptor blockade.
Clarification on neuromuscular conditions in careers article.
Health related quality of life in patients recently diagnosed with multiple sclerosis.
Lack of association between AQP4 polymorphisms and risk of inflammatory demyelinating disease in a Korean population.
Reducing survey burden: feasibility and validity of PROMIS measures in multiple sclerosis.
New analysis indicates that Novartis drug Gilenya shows significant early effect on reducing brain volume loss at 6 months
An exploratory study of decision making by informal caregivers of individuals with multiple sclerosis.
Quantitative Susceptibility Mapping in Multiple Sclerosis.
[Vitamin D and multiple sclerosis].
[NMO Spectrum Disorders and Anti AQP4 Antibody].
Functional connectivity analyses using emulated and conventional resting state data: Parts vs. the whole story.
CXCL13 antibody for the treatment of autoimmune disorders.
Acid Sphingomyelinase-Derived Ceramide Regulates ICAM-1 Function during T Cell Transmigration across Brain Endothelial Cells.
The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation.
Dynamics of sodium channel Nav1.5 expression in astrocytes in mouse models of multiple sclerosis.

Pages